Guangzhou Wondfo Biotech Co.,Ltd

SZSE:300482 Stock Report

Market Cap: CN¥11.3b

Guangzhou Wondfo BiotechLtd Dividends and Buybacks

Dividend criteria checks 2/6

Guangzhou Wondfo BiotechLtd is a dividend paying company with a current yield of 1.69% that is well covered by earnings.

Key information

1.7%

Dividend yield

-7.4%

Buyback Yield

Total Shareholder Yield-5.7%
Future Dividend Yield1.7%
Dividend Growth18.0%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.400
Payout ratio35%

Recent dividend and buyback updates

Recent updates

Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Nov 18
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 01
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Sep 06
Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Jul 27
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

Apr 29
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

Mar 27
A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Feb 29
There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 300482 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 300482's dividend payments have increased, but the company has only paid a dividend for 9 years.


Dividend Yield vs Market

Guangzhou Wondfo BiotechLtd Dividend Yield vs Market
How does 300482 dividend yield compare to the market?
SegmentDividend Yield
Company (300482)1.7%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Medical Equipment)1.7%
Analyst forecast (300482) (up to 3 years)1.7%

Notable Dividend: 300482's dividend (1.69%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 300482's dividend (1.69%) is low compared to the top 25% of dividend payers in the CN market (2.15%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (35.3%), 300482's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its high cash payout ratio (178.4%), 300482's dividend payments are not well covered by cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:20
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangzhou Wondfo Biotech Co.,Ltd is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Jingwei QiChina Merchants Securities Co. Ltd.